These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psychiatric symptoms with initiation of carbidopa-levodopa treatment. Lin JT; Ziegler DK Neurology; 1976 Jul; 26(7):699-700. PubMed ID: 945518 [TBL] [Abstract][Full Text] [Related]
3. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report. Savery F Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863 [No Abstract] [Full Text] [Related]
4. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment]. Martínez-Lage JM; Burguera JA; Deldago G; Zubieta JL Arch Neurobiol (Madr); 1978; 41(1):3-18. PubMed ID: 697513 [No Abstract] [Full Text] [Related]
5. The effects of combining carbidopa with levodopa for Parkinson's disease. Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406 [No Abstract] [Full Text] [Related]
6. Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa. Lipper S Lancet; 1976 Sep; 2(7985):571-2. PubMed ID: 60643 [No Abstract] [Full Text] [Related]
7. Levodopa with benserazide or carbidopa in Parkinson disease. Rinne UK; Mölsä P Neurology; 1979 Dec; 29(12):1584-9. PubMed ID: 574221 [TBL] [Abstract][Full Text] [Related]
9. [Carbidopa-levodopa, growth hormone and parkinsonism]. Marti-Masso JF; Carrera N; Martínez-Lage JM Rev Clin Esp; 1976 Jun; 141(6):525-32. PubMed ID: 968087 [No Abstract] [Full Text] [Related]
10. Treatment of "on-off effect" with a dopa decarboxylase inhibitor. Sweet RD; McDowell FH; Wasterlain CG; Stern PH Arch Neurol; 1975 Aug; 32(8):560-3. PubMed ID: 1156214 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa]. Lombardo L; De la Garza R Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417 [TBL] [Abstract][Full Text] [Related]
13. L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. Glasgow GL; Henley JW; Willoughby EW Aust N Z J Med; 1974 Aug; 4(4):373-8. PubMed ID: 4278910 [No Abstract] [Full Text] [Related]
14. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor]. Londoõ R Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729 [TBL] [Abstract][Full Text] [Related]
15. [The clinical experience with the decarboxylase-blocked levodopa (Nacom) in the Parkinsonism patients]. Völler GW; Deze J ZFA (Stuttgart); 1976 Mar; 52(7):380-8. PubMed ID: 773025 [No Abstract] [Full Text] [Related]
16. Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline. Rampton DS Br Med J; 1977 Sep; 2(6087):607-8. PubMed ID: 901999 [No Abstract] [Full Text] [Related]
17. The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor. Rivera-Calimlim L; Tandon D; Anderson F; Joynt R Arch Neurol; 1977 Apr; 34(4):228-32. PubMed ID: 843257 [TBL] [Abstract][Full Text] [Related]
19. Controversies in the treatment of Parkinson's disease. Friedman J R I Med J (1976); 1985 Oct; 68(10):461-3. PubMed ID: 3865336 [No Abstract] [Full Text] [Related]
20. Causes of pseudotumor cerebri and papilledema. Barone DA; Martin HL Arch Intern Med; 1979 Jul; 139(7):830-1. PubMed ID: 454080 [No Abstract] [Full Text] [Related] [Next] [New Search]